Camelid single-domain antibodies: historical perspective and future outlook

From National Research Council Canada

Download
  1. (PDF, 805 KiB)
DOIResolve DOI: https://doi.org/10.3389/fimmu.2017.01589
AuthorSearch for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Subjectcamelid single-domain antibody; heavy chain antibody; VhH; nanobody; antibody engineering; therapeutic antibody
Abstract
Publication date
PublisherFrontiers Media
In
LanguageEnglish
Peer reviewedYes
NPARC number23002528
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifiere01626cc-59b9-436b-9d95-8396354ba2ae
Record created2017-11-22
Record modified2020-05-30
Date modified: